KalVista Pharmaceuticals, Inc. (KALV)

20.48 +0.92 (+4.70%) USD  |  NASDAQ  |  Apr 17, 16:00
20.51 +0.03 (+0.15%) After-Hours: 20:00
More

KalVista Pharmaceuticals Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
Modular Medical, Inc. --
Iovance Biotherapeutics, Inc. Upgrade